Fewer Structure/Function Claims Deemed Inappropriate By FDA In 1999
This article was originally published in The Tan Sheet
Cold, allergy and immune system claims were the most commonly cited statements in FDA "courtesy" letters issued to dietary supplement companies in 1999, although the number of letters addressing these conditions declined from 1998.
You may also be interested in...
FDA plans to revisit its use of "courtesy" letters to respond to inappropriate dietary supplement claims, Center for Food Safety & Applied Nutrition's Robert Moore, PhD, said at a joint CRN/CHPA briefing in Washington, D.C. Feb. 16.
McNeil Consumer Healthcare opposes FDA's classification of certain cholesterol-lowering claims as disease claims in the final rule on dietary supplement structure/function claims. In a Feb. 7 citizen petition, McNeil asks the agency to reconsider its decision.
FDA's reversal on structure/function claims for pregnancy-related conditions is likely to reinvigorate Capitol Hill debate over the agency's regulation of dietary supplements.